SCHEMBL17084309

SCHEMBL17084309

CCCCCCC1(CCCCCC)c2cc(C(=O)c3ccccc3C)ccc2-c2ccc(/C(C)=N\C)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.36
▸ HTT P42858 1/20 0.36
▸ CNR2 P34972 3/20 0.35
▸ MAPK13 O15264 2/20 0.34
▸ MAPK12 P53778 2/20 0.34
▸ MAPK11 Q15759 2/20 0.34
▸ MAPK14 Q16539 2/20 0.34
▸ PDK2 Q15119 1/20 0.33
▸ F2R P25116 1/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ PTPN11 Q06124 1/20 0.32
▸ RARB P10826 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ RAB9A P51151 2/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17084310 0.92 ALDH1A1 (0.39) ALDH1A1HTTMAPK13MAPK12MAPK11
SCHEMBL17056226 0.88 ALDH1A1 (0.34) ALDH1A1HTTCNR2MAPK13MAPK12
SCHEMBL17084318 0.87 PDK2 (0.41) ALDH1A1CNR2PDK2
SCHEMBL16477967 0.85 CNR2 (0.39) ALDH1A1HTTCNR2MAPK13MAPK12
SCHEMBL21168758 0.84 PDK2 (0.41) ALDH1A1HTTCNR2MAPK13MAPK12
SCHEMBL19186319 0.83 ALDH1A1 (0.39) ALDH1A1HTTMAPK13MAPK12MAPK11
SCHEMBL17084349 0.83 ALDH1A1 (0.39) ALDH1A1HTTMAPK13MAPK12MAPK11
SCHEMBL30266914 0.80 PDK2 (0.42) ALDH1A1HTTMAPK13MAPK12MAPK11
SCHEMBL17084352 0.80 PDK2 (0.42) ALDH1A1HTTMAPK13MAPK12MAPK11
SCHEMBL17877627 0.80 ALDH1A1 (0.36) ALDH1A1HTTMAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR AFF1, AFF2, FTO ALDH1A1 290/4885HTT 1962/4885CNR2 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback